Multicentre Comparison of the Toxicity and Effectiveness of Lobaplatin-Based Versus Cisplatin-Based Adjuvant Chemotherapy in Oesophageal Carcinoma

OBJECTIVES: Lobaplatin (LBP), a third-generation cisplatin derivative has shown promising activity and few side effects in oesophageal squamous cell carcinoma (ESCC) in previous reports. We compared LBP plus docetaxel with cisplatin plus docetaxel as adjuvant chemotherapy in ESCC patients to determi...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Yan, Li, Yin, Liu, Xianben, Sun, Haibo, Liang, Guanghui, Hu, Jiajia, Li, Liping, Xing, Wenqun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8474464/
https://www.ncbi.nlm.nih.gov/pubmed/34589419
http://dx.doi.org/10.3389/fonc.2021.668140

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8474464/
https://www.ncbi.nlm.nih.gov/pubmed/34589419
http://dx.doi.org/10.3389/fonc.2021.668140

Ejemplares similares